Playground →
Amgen's top 10 neighbors split evenly between two subcategories — Healthcare brands and B2B services firms — with no single neighbor pulling far ahead of the rest.
The shape is flat: scores run from 0.97 down to 0.94 across the top 10, a narrow band with no dominant anchor. Five neighbors are Healthcare brands: AstraZeneca (0.97), Novartis (0.97), GSK (0.96), Bristol Myers Squibb (0.96), and Pfizer Inc. (0.94). The other five are B2B services firms: Accenture (0.96), Deloitte (0.95), Boston Consulting Group (0.94), and IBM (0.94), with Marc Benioff (0.94) — a Tech Personality — rounding out the set. That last entry is the one cross-kind outlier: nine of the ten neighbors are institutional brands, but a named individual sits at the same similarity level as the consulting giants. No media outlets, no consumer brands, and no government entities appear in the top 10, though all exist in the broader graph. The Healthcare–B2B split is the defining structural feature: Amgen's audience looks as much like the audience for a major management consultancy or enterprise services firm as it does like the audience for a pharmaceutical peer.
This dual composition points to an audience that moves fluidly between clinical and corporate professional contexts — pharma pipelines on one side, enterprise strategy on the other.
